drugset / Trial / NCT04290325
HMPL-453 in Advanced Malignant Mesothelioma
NaSingle-groupOpen-labelTreatment
Summary
This is a phase II, single arm, multicenter and open-label study to evaluate the efficacy, safety and pharmacokinetic of HMPL-453 in patient with advanced Malignant Mesothelioma
Timeline
- Start
- 2019-12-30
- Primary completion
- 2022-11-30
- Completion
- 2023-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HMPL-453 | Unknown | — | — |